Showing results (841-850 of 3,789) with videos related to
Sort By:
Pageof 379
Oncoimmunology|April 11, 2024
Redoxhigh phenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mutations diminishes tissue-resident memory CD8+ T cells and attenuates the efficacy of immunotherapy in lung adenocarcinomaXue-Wu Wei, Chang Lu, Yi-Chen Zhang, et al.Oncoimmunology|January 6, 2026
Unlocking the therapeutic potential of immuno-radiotherapy: insights from preclinical and clinical researchM M Cogels, A de Caluwé, L Buisseret, et al.Oncoimmunology|January 11, 2026
DNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 + T cell responses and therapeutic protection in mouse tumor modelsPablo Morgado-Cáceres, Francisca Hofmann-Vega, Diego Figueroa, et al.Oncoimmunology|December 24, 2024
Induction of cell death in malignant cells and regulatory T cells in the tumor microenvironment by targeting CD137Rui Sun, Kang Yi Lee, Yu Mei, et al.Oncoimmunology|January 15, 2025
Current landscape and future prospects of interleukin-2 receptor (IL-2R) agonists in cancer immunotherapyKengo Tanigawa, William L RedmondOncoimmunology|December 21, 2023
Piezo1 facilitates optimal T cell activation during tumor challengeMuta Abiff, Mohammad Alshebremi, Melissa Bonner, et al.Oncoimmunology|January 3, 2024
Cerebrospinal fluid immunological cytokines predict intracranial tumor response to immunotherapy in non-small cell lung cancer patients with brain metastasesMeichen Li, Jing Chen, Hui Yu, et al.Oncoimmunology|January 3, 2024
Unbiased high-dimensional flow cytometry identified NK and DC immune cell signature in Luminal A-type and triple negative breast cancerLukas Heger, Gordon F Heidkamp, Lukas Amon, et al.Oncoimmunology|December 21, 2023
MHCII restriction demonstrates B cells have very limited capacity to activate tumour-specific CD4+ T cells in vivoThomas V Guy, Alexandra M Terry, Helen M McGuire, et al.Oncoimmunology|December 21, 2023
LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with metastatic soft tissue sarcomaMorten Nielsen, Tine Monberg, Vibeke Sundvold, et al.Pageof 379